Aesyra, a medical device company developing oral appliance technologies to improve sleep, raised $3 million in seed financing to support the development and commercialization of the AesyBite line of products for accurate monitoring and treatment of sleep bruxism and sleep apnea.
The round was led by Supermoon Capital (USA), a fund focused on sleep tech, and deep tech investor Creadd Ventures (Switzerland) with participation from existing investor Zürcher Kantonalbank.
A spin-off of the Federal Institute of Technology of Lausanne (EPFL) in Switzerland, Aesyra has pioneered a powerful technology system—that combines a unique oral appliance device, proprietary sensors, and artificial intelligence—that has demonstrated over 70% reduction of bruxism activity for users, according to a release from Aesyra. Powering Aesyra’s AesyBite is technology developed by EPFL researchers and algorithms that leverage over 10 years of sleep research data.
“This significant investment marks a pivotal moment for Aesyra,” says Marco Letizia, founder and CEO of Aesyra, in a release. “We are thrilled to partner with Supermoon Capital and Creadd Ventures, who share our vision of driving meaningful change within the sleep industry. With their support, we are well-positioned to accelerate the deployment of our groundbreaking solutions, ultimately improving patient outcomes and advancing healthcare practices.”
Michael Masterson, managing partner at Supermoon Capital, and Lorenzo Leoni, founder and managing partner at Creadd Ventures, will join the board of directors of Aesyra.
Photo 25500092 © Gan Hui | Dreamstime.com
